References
- Ahokas A, Elonen E. Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology (Berlin) 1999; 144: 301–302
- Akbulut H, Icli F, Büyükcelik A, Akbulut KG, Demirci S. The role of granulocyte-macrophage-colony stimulating factor, cortisol and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer. J Pineal Res 1999; 26(1)1–8
- Atkin K, Kendall F, Gould D, Freeman H, Lieberman J, O'Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483–488
- Esposito D, Aouille J, Rouillon F, Limosin F. Morning pseudoneutropenia during clozapine treatment. World J Biol Psychiatry 2003; 4: 192–194
- Esposito D, Aouille J, Rouillon F, Limosin F. Two year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia. J Clin Psychiatry 2004; 65: 1281
- Jauss M, Pantel J, Werle E, Schröder J. G-CSF plasma levels in clozapine-induced neutropenia. Biol Psychiatry 2000; 48(11)1113–1115
- Jilma B, Hergovich N, Stohlawetz P, Eichler HG, Bauer P, Wagner OF. Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol 1999; 106(2)368–370
- Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12760 clozapine recipients in the UK and Ireland. Br J Psychiatry 1999; 175: 576–580
- Porter R, Mohamed A. Diurnal variation of neutropenia during clozapin treatment. Int J Neuropsychopharmacol 2006; 9: 373–374
- Schuld A, Kraus T, Hinze-Selch D, Haack M, Pollmächer T. Granulocyte colony stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatr Scand 2000; 102(2)153–155
- Whiskey E, Taylor D. Restarting clozapine after neutropenia: evaluating the possibilities and practicabilities. CNS Drugs 2007; 21(1)25–35